The purpose of this trial is to test the ability of the non-steroidal anti-inflammatory
medications naproxen and celecoxib to delay or prevent the onset of AD and age-related
cognitive decline.
Phase:
Phase 3
Details
Lead Sponsor:
Seattle Institute for Biomedical and Clinical Research
Collaborators:
Johns Hopkins University National Institute on Aging (NIA) University of Washington VA Puget Sound Health Care System